Aviva add Oncotype DX scan benefit to all plans 30.11.10

Aviva Health will add a benefit for Oncotype DX scans to all plans from 30 November 2010. Oncotype DX is a genomic testing for HER positive node negative breast cancer to indicate the recurrence score for breast cancer returning in a 10 year time period. This benefit is available for listed hospitals only. Please contact Aviva for more details.